S&P 및 Nasdaq 내재가치 문의하기

Veracyte, Inc. VCYT NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
70/100
4/7 Pass
SharesGrow Intrinsic Value
$48.21
+40.6%
Analyst Price Target
$44.50
+29.7%

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Veracyte, Inc. (VCYT), 포함 7 건 매수42 건 매도. 내부자 매수 총액은 RSU 보상 내부자 매도 총액은 $11.45M.

최근 활동이 있는 주요 내부자에는 Haas Kevin Richard, Stapley Marc, Wygant Jonathan. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — VCYT

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2026-03-24 Haas Kevin Richard Officer 알 수 없음 - - - -
2026-03-06 Stapley Marc Chief Executive Officer RSU 부여 92,099 - - 449,653
2026-03-06 Wygant Jonathan VP, Chief Accounting Officer RSU 부여 10,525 - - 45,434
2026-03-06 Febbo Phillip G. Chief Scientific & Med Officer RSU 부여 29,603 - - 146,949
2026-03-06 Chambers Rebecca Chief Financial Officer RSU 부여 36,181 - - 167,377
2026-03-06 Mcguire Annie SVP, General Counsel RSU 부여 32,892 - - 127,598
2026-03-06 Leite John Chief Commercial Officer-clia RSU 부여 36,181 - - 143,761
2026-03-04 Stapley Marc Chief Executive Officer 정보 매도 26,279 $36.28 $953.37K 357,554
2026-03-04 Chambers Rebecca Chief Financial Officer 정보 매도 13,941 $36.33 $506.46K 131,196
2026-03-04 Mcguire Annie SVP, General Counsel 정보 매도 1,664 $36.34 $60.47K 94,706
2026-03-04 Leite John Chief Commercial Officer-clia 정보 매도 5,260 $35.19 $185.08K 107,580
2026-03-02 Stapley Marc Chief Executive Officer RSU 원천징수 19,455 $36.01 $700.57K 403,077
2026-03-02 Wygant Jonathan VP, Chief Accounting Officer RSU 원천징수 3,006 $36.01 $108.25K 34,909
2026-03-02 Febbo Phillip G. Chief Scientific & Med Officer 정보 매도 13,425 $36.16 $485.43K 117,346
2026-03-02 Chambers Rebecca Chief Financial Officer RSU 원천징수 7,234 $36.01 $260.5K 149,537
2026-03-02 Mcguire Annie SVP, General Counsel RSU 원천징수 6,902 $36.01 $248.54K 101,364
2026-03-02 Leite John Chief Commercial Officer-clia RSU 원천징수 7,517 $36.01 $270.69K 112,840
2026-02-26 Stapley Marc Chief Executive Officer RSU 원천징수 35,841 $38.75 $1.39M 422,532
2026-02-26 Febbo Phillip G. Chief Scientific & Med Officer RSU 원천징수 24,486 $38.75 $948.83K 136,806
2026-02-26 Chambers Rebecca Chief Financial Officer RSU 원천징수 12,049 $38.75 $466.9K 156,771
2026-02-26 Mcguire Annie SVP, General Counsel RSU 원천징수 10,867 $38.75 $421.1K 108,266
2026-02-26 Leite John Chief Commercial Officer-clia RSU 원천징수 8,905 $38.75 $345.07K 120,357
2025-12-16 Mcguire Annie SVP, General Counsel 정보 매도 100 $43.68 $4.37K 67,760
2025-12-05 Eastham Karin Director 옵션 행사 (매도) 10,000 $7.94 $79.4K -
2025-12-04 Stapley Marc Chief Executive Officer 정보 매도 3,220 $47.35 $152.46K 318,603
2025-12-04 Chambers Rebecca Chief Financial Officer 정보 매도 4,741 $47.25 $224.01K 109,496
2025-12-04 Mcguire Annie SVP, General Counsel 정보 매도 702 $47.51 $33.35K 78,499
2025-12-04 Leite John Chief Commercial Officer-clia 정보 매도 1,278 $47.51 $60.72K 82,113
2025-12-02 Stapley Marc Chief Executive Officer RSU 원천징수 7,914 $46.16 $365.31K 326,271
2025-12-02 Wygant Jonathan VP, Chief Accounting Officer RSU 원천징수 1,325 $46.16 $61.16K 37,420
2025-12-02 Febbo Phillip G. Chief Scientific & Med Officer RSU 원천징수 2,955 $46.16 $136.4K 89,486
2025-12-02 Chambers Rebecca Chief Financial Officer RSU 원천징수 3,384 $46.16 $156.21K 122,774
2025-12-02 Mcguire Annie SVP, General Counsel RSU 원천징수 3,052 $46.16 $140.88K 79,921
2025-12-02 Leite John Chief Commercial Officer-clia RSU 원천징수 2,900 $46.16 $133.86K 83,391
2025-11-25 Jones Evan/ Fa Director 정보 매도 1,106 $50.25 $55.58K 29,362
2025-11-25 Leite John Chief Commercial Officer-clia 정보 매도 2,808 $50.00 $140.4K 86,291
2025-11-20 Holstein Jens Director 정보 매도 1,460 $43.21 $63.09K 27,199
2025-11-10 Wygant Jonathan VP, Chief Accounting Officer 정보 매도 5,102 $42.33 $215.98K 38,745
2025-11-07 Wygant Jonathan VP, Chief Accounting Officer 정보 매도 5,818 $40.21 $233.93K 43,847
2025-11-05 Jones Evan/ Fa Director 옵션 행사 (매도) 10,000 $5.28 $52.8K -
2025-11-05 Eastham Karin Director 정보 매도 9,674 $40.02 $387.19K 13,554
2025-11-05 Chambers Rebecca Chief Financial Officer 정보 매도 7,000 $41.00 $287K 126,158
2025-11-05 Mcguire Annie SVP, General Counsel 정보 매도 6,466 $40.00 $258.64K 82,973
2025-10-28 Wygant Jonathan VP, Chief Accounting Officer RSU 부여 2,886 - - 49,665
2025-10-06 Febbo Phillip G. Chief Scientific & Med Officer 정보 매도 8,349 $36.02 $300.71K 92,441
2025-10-01 Epstein Robert S Director 옵션 행사 (매도) 10,000 $7.94 $79.4K -
2025-10-01 Mcguire Annie SVP, General Counsel 정보 매도 2,160 $35.00 $75.61K 89,439
2025-10-01 Leite John Chief Commercial Officer-clia 정보 매도 2,539 $35.00 $88.87K 89,099
2025-09-19 Mcguire Annie SVP, General Counsel 정보 매도 2,283 $33.69 $76.92K 91,599
2025-09-04 Stapley Marc Chief Executive Officer 정보 매도 7,667 $30.41 $233.13K 334,185
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기